April 02, 2013 03:14 am | Updated December 04, 2021 11:39 pm IST
Novartis had sought to overturn a clause in Indian Patents Law that restricts patent protection for newer forms of existing molecules. The case started in 1997 when Novartis filed a plea for a patent for Glivec.
Following is the timeline of the patent case in India.
1997 : Novartis files a patent application in India for its drug Gilvec
ADVERTISEMENT
2005 : India introduces the Indian Patent Act preventing frivolous patents.
ADVERTISEMENT
Jan 2006 : The Patent Controller in Chennai denies Novartis a patent
May 2006 : Novartis challenges the Indian government and four other companies in the Madras High Court
ADVERTISEMENT
Aug 2007 : The Madras High Court rules against Novartis’ case
ADVERTISEMENT
June 2009 : The Intellectual Property Appellate Board rejects a fresh appeal
August 2009 : Novartis approaches the Supreme Court of India
April 1, 2013 : Supreme Court rejects Novartis’ plea for patent
This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every
month
You have exhausted your free article limit.
Please support quality journalism.
You have exhausted your free article limit.
Please support quality journalism.
The Hindu operates by its editorial values to provide you quality journalism.
You have read {{data.cm.views}} out of {{data.cm.maxViews}} free articles.